A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.

Diagnosis can clarify the struggle. But when explanation turns into identity, possibility shrinks. The difference determines whether growth continues.

Therians have roamed around for years on internet forums, but TikTok has shined a light on the previously hidden herds. Therians identify themselves as non-human animals and claim that this identity ...

Tez Anderson didn't understand why he was experiencing extreme stress, isolation, and nightmares until he realized he has ...

Using a filter that surrounded her face with distorted rays of light, the girl said she’d been crying tears of joy. She’d reached 102 subscribers on her YouTube channel, where she’d been uploading ...

Rovier Carrington thought his cases against MTV and Paramount executives should have been the biggest of the #MeToo era. Instead, they raised unsettling questions about victimhood ...

This study suggests is that clinicians "may be able to offer patients a path to meaningful relief in less than 1 week." ...

A weeklong, high-intensity version of TMS may work nearly as well as the standard six-week treatment for depression. In a UCLA study, patients who received five sessions a day for five days ...

A depression diagnosis may contribute to kidney disease progression for adults with chronic kidney disease, according to study data published in Frontiers in Nephrology. Depression has been linked to ...

For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS) - ...

Living with prostate cancer can be very stressful. It can affect a person’s body, life plans, relationships, and emotions. Many people don’t realize that people with prostate cancer are at risk for ...

FDA grants Breakthrough Therapy designation to luvesilocin for postpartum depression following positive results from the phase 2 RECONNECT trial.